Baystate Wealth Management’s Avanos Medical AVNS Stock Holding History

Baystate Wealth Management’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1	Closed	–	–	876
2021 Q3	$0	Hold	1	–	–	﹤0.01%	835
2021 Q2	$0	Hold	1	–	–	﹤0.01%	801
2021 Q1	$0	Hold	1	–	–	﹤0.01%	730
2020 Q4	$0	Hold	1	–	–	﹤0.01%	681
2020 Q3	$0	Hold	1	–	–	﹤0.01%	643
2020 Q2	$0	Hold	1	–	–	﹤0.01%	654
2020 Q1	$0	Hold	1	–	–	﹤0.01%	600
2019 Q4	$0	Hold	1	–	–	﹤0.01%	621
2019 Q3	$0	Hold	1	–	–	﹤0.01%	576
2019 Q2	$1K	Hold	1	–	–	﹤0.01%	530
2019 Q1	$1K	Hold	1	–	–	﹤0.01%	541
2018 Q4	$1K	Hold	1	–	–	﹤0.01%	546
2018 Q3	$1K	Hold	1	–	–	﹤0.01%	563
2018 Q2	$1K	Hold	1	–	–	﹤0.01%	582
2018 Q1	$1K	Hold	1	–	–	﹤0.01%	543
2017 Q4	$1K	Hold	1	–	–	﹤0.01%	547
2017 Q3	$1K	Hold	1	–	–	﹤0.01%	530
2017 Q2	$1K	Hold	1	–	–	﹤0.01%	546
2017 Q1	$1K	Buy	+1	New	+$39	﹤0.01%	510

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Baystate Wealth Management's AVNS Position: Q4 2021 in Review

Baystate Wealth Management sold out of Avanos Medical (AVNS) in Q4 2021, closing a stake of 1 share.

Baystate Wealth Management first reported a position in AVNS in Q1 2017 and held it in 19 quarters. The position peaked at $1K in Q2 2019. 297 funds tracked by Wall St. Rank hold AVNS as of Q4 2021.

Baystate Wealth Management reported no remaining Avanos Medical position as of Q4 2021 after selling out during the quarter.
Baystate Wealth Management sold 1 Avanos Medical share in Q4 2021.
Baystate Wealth Management first reported a position in Avanos Medical in Q1 2017 and held it in 19 quarters.
Baystate Wealth Management's Avanos Medical position peaked at $1K in Q2 2019.
297 funds tracked by Wall St. Rank held Avanos Medical as of Q4 2021.

Based on Baystate Wealth Management's 13F filing for Q4 2021, filed 21 Jan 2022.